RxDoctor Payments Data

Brett Driver

Family · Frisco, TXNPI 1295326031

Payments from drug & device makers

$2,263in general payments, 2019–2025

Across 120 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$349
  • AbbVie$230
  • Exact Sciences$175
  • Lilly USA, LLC$152
  • Biohaven Pharmaceutical Holding Company Ltd.$138
  • Amgen$118
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$2,263100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,263 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide31$32,014
XareltoRivaroxaban14$12,759
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,202
Wixela InhubFluticasone Propion/Salmeterol13$1,082
Testosterone Cypionate23$691
Rosuvastatin Calcium68$674
SynthroidLevothyroxine Sodium14$581
Tamsulosin Hcl28$565
Cefdinir34$538
Amlodipine Besylate51$480
Oxybutynin Chloride ErOxybutynin Chloride18$471
Trazodone Hcl41$463
Atorvastatin Calcium43$440
Omeprazole24$423
Metoprolol Succinate17$357

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$152$32,01431 claims
AbbVieSynthroid$230$58114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 15,456 family providers in Texas.

Other family in Frisco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →